DAILIES TOTAL DALIES TOTAL FOR ASTIGMATISM DAILIES TOTAL MULTIFOCAL DAILIES TOTAL MULTIFOCAL TORIC
Applicant
Ciba Vision Corporation
Product Code
LPL · Ophthalmic
Decision Date
Mar 30, 2012
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 886.5925
Device Class
Class 2
Intended Use
DAILIES TOTAL 1® (delefilcon A) spherical soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism. DAILIES TOTAL 1® (delefilcon A) toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism. DAILIES TOTAL 1 (delefilcon A) multifocal soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism. DAILIES TOTAL 1® (delefilcon A) multifocal toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less. The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.
Device Story
Delefilcon A soft contact lenses; silicone hydrogel material with phosphatidylcholine; water gradient design (33% water core to >80% surface water). Function as refractive medium on cornea to focus light on retina. Prescribed by eye care professionals for daily disposable wear; patient self-use. Packaged in phosphate buffered saline with polymeric wetting agents; steam sterilized. Benefits include vision correction with high oxygen permeability (140 Dk).
Clinical Evidence
Prospective, randomized, parallel group 3-month clinical study; 60 test (delefilcon A) vs 30 control (narafilcon B) subjects. Primary endpoints: biomicroscopy (safety) and visual acuity (efficacy). Additional metrics: refraction, keratometry, subjective ratings of vision, comfort, and handling. Results showed similar performance between test and control lenses.
Technological Characteristics
Material: 33% water/67% delefilcon A (silicone hydrogel with phosphatidylcholine). Water gradient surface (>80% water). Oxygen permeability: 140 x 10-11. Refractive index: 1.42. Light transmittance: ≥ 93%. Manufacturing: LightStream. Sterilization: Moist heat (autoclave). Packaging: Blister pack with phosphate buffered saline and polymeric wetting agents.
Indications for Use
Indicated for optical correction of refractive ametropia (myopia, hyperopia, astigmatism, presbyopia) in phakic or aphakic persons with non-diseased eyes. Specific astigmatism and reading addition limits apply by lens type. For single-use, daily disposable wear.
Regulatory Classification
Identification
A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.
Predicate Devices
Johnson & Johnson VISTAKON 1-DAY ACUVUE TruEye (narafilcon B) (K100349)
{0}------------------------------------------------
| MAR | 3 |
|-----|------|
| 0 | 2012 |
Image /page/0/Picture/1 description: The image shows a sequence of handwritten digits and a letter. The sequence starts with the letter 'K', followed by the numbers '113168'. The numbers are written in a simple, slightly irregular style, typical of handwriting.
**CIDA VISION.**
Shared Passion for Healthy Vision and Better Life
CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097
27-Mar-2012, v03 Page 1 of 4
# Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence
# 510(k) Summary - K113168
# 1. Submitter Information:
| Company: | CIBA VISION Corporation<br>11460 Johns Creek Parkway<br>Duluth, Georgia USA 30097 |
|------------------------------------|-----------------------------------------------------------------------------------|
| Contact Person: | Alicia M. Plesnarski, RAC<br>Director, Regulatory Affairs |
| Telephone:<br>Facsimile:<br>Email: | 678-415-3924<br>678-415-3454<br>alicia.plesnarski@cibavision.com |
### 2. Device Name:
Date Prepared:
- Soft Contact Lens ● Common Name:
- DAILIES TOTAL 1® (delefilcon A) Trade/Proprietary Name: .
27-Mar-2012
- Daily Wear Soft Contact Lens � Classification Name:
- Class II [21 CFR 886.5925 (b) (1)] Device Classification: .
## 3. Predicate Device:
· The predicate device is Johnson & Johnson VISTAKON® 1-DAY ACUVUE® TruEye (narafilcon B) soft contact lenses packaged in buffered saline. Narafilcon B lenses belona to ISO Group V (silicone hydrogel). Johnson & Johnson VISTAKON 1-DAY ACUVUE TruEye lenses have FDA 510(k) clearance per K100349, 21-May-2010.
### 4. Description of Device:
The lens material is 33% water and 67% delefilcon A, a silicone containing hydrogel with added phosphatidylcholine. The core lens material containing 33% water transitions through a water gradient to a hydrogel surface layer that exceeds 80% water. Lenses contain the color additive copper phthalocyanine, a light blue handling tint, which makes them easier to see when handling
Delefilcon A lens designs include spherical, toric, multifocal and toric multifocal lenses in the following parameter ranges:
- 13.0 to 15.0 mm . Diameter Range:
- Base Curve Range: 8.0 to 9.2 mm .
- -20.00D to +20.00D � Power Range:
- Center Thickness: varies with design and power � (0.09 mm for -3.00D spherical)
{1}------------------------------------------------
**CIBA**VISION.
*Shared Passion for Healthy Vision and Better Life*
.
CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097
27-Mar-2012. v03 Page 2 of 4
# Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence
Lenses have the following properties:
- 1.42 (hydrated) Refractive index: .
- ≥ 93% (@610 nm, -1.00D) Light transmittance:
- 33% by weight in normal saline Water content: .
- Surface water content: ≥ 80% .
- 140 x 10-11 Oxygen permeability . [{cm2 /sec)(ml O2 /ml.mmHg}] measured at 35°C (intrinsic Dk-Coulometric method)
Each lens is packaged in a foil-sealed plastic containing phosphate buffered saline solution with approximately 0.3% of polymeric wetting agents consisting of copolymers of polyamidoamine and poly(acrylamide-acrylic acid) and are steam sterilized. The compatibility and package integrity of the blister pack packaging system has been demonstrated and successfully used for other marketed contact lens products, and packaged lenses are effectively steam sterilized in a validated autoclave. Blister pack containers are labeled with the lens parameters, lot number and product expiration date. The expiration date has been established through stability studies that have assessed the chemical and physical stability of the lens and integrity of the package (ability to maintain sterility). Shelf-life studies are ongoing to establish and extend the labeled expiration date.
## 5. Indications for Use:
DAILIES TOTAL1® (delefilcon A) spherical soft contact ienses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with up to approximately 1.50 diopters of astigmatism.
DAILIES TOTAL 10 for Astigmatism (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic or aphakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism.
DAILIES TOTAL 1 Multifocal (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism.
DAILIES TOTAL 1 Multifocal Toric (delefilcon A) soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less.
The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.
{2}------------------------------------------------
| <b>CIBA</b> <img alt="eye logo" src=""/> <b>VISION</b> <sup>TM</sup> |
|----------------------------------------------------------------------|
| Shared Passion for Healthy Vision and Better Life |
CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097
27-Mar-2012, v03 Page 3 of 4
# Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence
# 6. Description of Safety and Substantial Equivalence:
A series of non-clinical tests were performed to characterize lens material properties and establish substantial equivalence to the predicate device. All testing was conducted in accordance with the May 1994 FDA guidance document titled Premarket Notification 510(k) Guidance Document for Daily Wear Contact Lenses and in conformance to applicable device regulations. Results verify that delefilcon A contact lenses are nontoxic and biocompatible, have material characteristics in common with currently marketed soft contact lenses intended for vision correction and demonstrate substantial equivalence to the previously FDA cleared predicate (control) lenses listed in Table 1.
| | Predicate Device | New Device |
|------------------------|-----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|
| Product Name | Johnson & Johnson®<br>VISTAKON® 1-DAY<br>ACUVUE® TruEye™<br>(narafilcon B) | CIBA VISION®<br>DAILIES TOTAL1®<br>(delefilcon A) |
| Intended Use | Daily Disposable Wear | Daily Disposable Wear |
| Mode of Action | When hydrated and placed on<br>the cornea, lenses act as a<br>refracting medium to focus<br>light rays on the retina. | When hydrated and placed on<br>the cornea, lenses act as a<br>refracting medium to focus<br>light rays on the retina. |
| 510(k) Number | K100349 | To be assigned |
| Lens Material Group ** | ISO Group V | ISO Group V |
| Manufacturing Method | Molded | LightStream |
| Sterilization Method | Moist Heat | Moist Heat |
| Packaging | Blister Pack | Blister Pack |
| Handling Tint | Lt. Blue | Lt. Blue |
| Refractive Index | 1.41 | 1.42 |
| Water Content (%) | 48 | 33 |
| Oxygen permeability | 55 | 140 |
| BC/Diameter (mm) | 8.5/14.2 | 8.5/14.1 |
| Power (D) | various | various |
Table 1. Substantial Equivalence Comparison
**Per EN ISO 18369-1/Amd.1:2009
{3}------------------------------------------------
K113168
**CIBA**VISION.
*Shared Passion for Healthy Vision and Better Life*
CIBA VISION Corporation 11460 Johns Creek Parkway Duluth, Georgia USA 30097
27-Mar-2012, v03 Page 4 of 4
Delefilcon A Soft Contact Lenses 510(k) Summary of Safety and Substantial Equivalence
### Conclusions drawn from Studies
### Nonclinical Testing:
A series of nonclinical testing was performed to verify substantial equivalence of delefiloon A contact lenses to the predicate device. Non-clinical biocompatibility testing was conducted in accordance with the GLP regulation (21 CFR Part 58). The results of all non-clinical testing demonstrate:
- The lens material and extracts of the device are non toxic and non-irritating. .
- The device has optical, dimensional and physico-chemical properties in common . with currently marketed soft contact lenses intended for vision correction and consistent with or better than, the predicate lenses tested.
- The lenses are compatible with commonly available contact iens rewetting drops and . saline solutions.
#### Clinical Testing:
A three-month clinical study was conducted to assess the safety and efficacy of DAILIES TOTAL1® (delefilcon A) soft contact lenses for single use, daily disposable wear. The clinical study also provided data to establish substantial equivalence with the predicate, control lens.
The study evaluated 60 delefilcon A (test) subjects in a 2:1 ratio with the 30 narafilcon B (control) subjects in a prospective, randomized, parallel group design. The primary safety and efficacy variables were biomicroscopy findings and visual acuity respectively. Additional variables tested include refraction, keratometry, and subjective ratings of vision, comfort and handling.
The study results showed similar performance between the test delefilcon A and control narafilcon B lenses in the clinically relevant areas of fit, vision, comfort, health and handling when worn on a daily disposable wear basis.
#### Risks and Benefits:
The risks of the subject device are the same as those normally attributed to the wearing of silicone hydrogel contact lenses on a single use, daily wear basis. The benefits to the patient are the same as those for other silicone hydrogel contact lenses.
#### Substantial Equivalence:
Delefilcon A soft contact lenses are substantially equivalent to the predicate contact lens and similar to other daily wear soft contact lenses in terms of material water content (33% water), ionic characteristics, ISO Group V: silicone hydrogel and indications for use.
Any differences which may exist between the delefilcon A soft contact lens and other ISO Group V silicone hydrogel soft contact lenses do not adversely affect the safety and effectiveness of the device when worn under single use, daily wear conditions.
{4}------------------------------------------------
Image /page/4/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features a stylized caduceus-like symbol with three lines extending upwards, representing health and human services. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the symbol.
# DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -- WO66-G609 Silver Spring, MD 20993-0002
Ciba Vision Corporation c/o Ms. Alicia M. Plesnarski, RAC Director, Regulatory Affairs 11460 Johns Creek Parkway Duluth, GA 30097
MAR 3 0 2012
Re: K113168
Trade/Device Name: DAILIES TOTAL1® (delefilcon A) Soft Contact Lenses
for Daily Disposable Wear Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) Contact Lens Regulatory Class: Class II Product Codes: LPL, MVN Dated: March 21, 2012 Received: March 22, 2012
Dear Ms. Plesnarski:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in-the Code of Federal-Regulations, Title 21, Parts 800 to 898 -- In-addition-FDA-maypublish further announcements concerning your device in the Federal Register.
{5}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Kesia Alexander
Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{6}------------------------------------------------
#### 510(k) Number (if known):
## K113168
Device Name:
DAILIES TOTAL 1® (delefilcon A) Soft Contact Lenses
Indications For Use:
DAILIES TOTAL 1® (delefilcon A) spherical soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with up to approximately 1.50 diopters (D) of astigmatism.
DAILIES TOTAL 1® (delefilcon A) toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) in phakic persons with non-diseased eyes with 6.00 diopters (D) or less of astigmatism.
DAILIES TOTAL 1 (delefilcon A) multifocal soft contact lenses are indicated for the optical correction of refractive ametropia (myopia and hyperopia) and/or presbyopia in phakic or aphakic persons with non-diseased eyes who may require a reading addition of +3.00 diopters (D) or less and who may have up to approximately 1.50 diopters of astigmatism.
DAILIES TOTAL 1® (delefilcon A) multifocal toric soft contact lenses are indicated for the optical correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in phakic or aphakic persons with non-diseased eyes. The lenses may be worn by persons who have 6.00 diopters (D) or less of astigmatism and who may require a reading addition of +3.00 diopters (D) or less.
The lenses are to be prescribed for single use, daily disposable wear. The lenses are not intended to be cleaned or disinfected and should be discarded after a single use.
X Prescription Use: AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH. Office of Device Evaluation (ODE)
Marc Robboy
---
(Division Sign-Off)
Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
510(k) Number K113168
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.